文献速递头颈外科

天然制剂预防头颈癌放化疗急性黏膜炎的随机双盲III期研究

Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
PubMed 文献 · Head Neck · 2017-05-31

本研究为双盲随机III期试验,比较蜂胶、芦荟、金盏花和洋甘菊混合天然制剂与安慰剂在头颈癌同步放化疗中预防急性黏膜炎的效果。

核心结论

  • 所选天然制剂不能预防头颈癌同步放化疗期间的急性黏膜炎。
  • V9.5w作为黏膜炎预测因素的作用得到确认。

研究设计与样本

  • 患者接受同步化疗-调强放疗(IMRT),随机给予天然制剂(蜂胶、芦荟、金盏花、洋甘菊)或匹配安慰剂。
  • 主要终点为体格检查按CTCAE 3.0版评定的3级黏膜炎。

关键数值与推荐

  • 3级黏膜炎依据CTCAE 3.0版评定。
  • V9.5w定义为每周接受至少9.5Gy的黏膜体积。

临床怎么用

  • 所选天然制剂不应用于预防头颈癌同步放化疗期间的急性黏膜炎。
  • V9.5w可作为黏膜炎风险评估的参考指标。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no widely accepted intervention in the prevention of acute mucositis during chemoradiotherapy for head and neck carcinoma. In the present double-blind study, we tested 4 natural agents, propolis, aloe vera, calendula, and chamomile versus placebo. METHODS: Patients undergoing concomitant chemo-intensity-modulated radiotherapy (IMRT) were given natural agent or matched placebo; grade 3 mucositis on physical examination according to Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 was the primary endpoint. Various covariates were tested at logistic regression, including the individual amount of mucosa receiving at least 9.5 Gy per week (V9.5w). RESULTS: One hundred seven patients were randomized from January 2011 to July 2014, and 104 were assessable (51%-49% were assigned to the placebo group and 53%-51% were assigned to the natural agent). Overall, 61 patients developed peak grade 3 mucositis with no difference between arms (P = .65). Conversely, V9.5w (P = .007) and primary site (P = .037) were independent predictors. CONCLUSION: The selected natural agents do not prevent mucositis, whereas the role of V9.5w is confirmed.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Marucci L, Farneti A, Di Ridolfi P, et al. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer. Head Neck. 2017. PMID: 28560780. doi:10.1002/hed.24832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。